ResearchMoz

Liver Cancer Global Clinical Trials Review, H2, 2012

GlobalData
Published Date » 2012-12-12
No. Of Pages » 159
     
  Liver Cancer Global Clinical Trials Review, H2, 2012  
     
  Summary  
   
 GlobalData's clinical trial report, Liver Cancer Global Clinical Trials Review, H2, 2012" provides data on the Liver Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Liver Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Liver Cancer. This report is built using data and information sourced from proprietary databases, primary...
Table of Contents

Table of Contents 2

List of Tables 5
List of Figures 6
Introduction 7
Liver Cancer 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Five Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Liver Cancer 24
Subjects Recruited Over a Period of Time 36
Prominent Sponsors 37
Top Companies Participating in Liver Cancer Therapeutics Clinical Trials 39
Prominent Drug Comparison 41
Clinical Trial Profiles 42
Clinical Trial Overview of Top Companies 42
Bayer AG 42
Clinical Trial Overview of Bayer AG 42
Bristol-Myers Squibb Company 44
Clinical Trial Overview of Bristol-Myers Squibb Company 44
Pfizer Inc. 45
Clinical Trial Overview of Pfizer Inc. 45
Taiho Pharmaceutical Co., Ltd. 46
Clinical Trial Overview of Taiho Pharmaceutical Co., Ltd. 46
Sanofi 47
Clinical Trial Overview of Sanofi 47
Novartis AG 48
Clinical Trial Overview of Novartis AG 48
Celsion Corporation 49
Clinical Trial Overview of Celsion Corporation 49
Pathfinder Therapeutics, Inc. 50
Clinical Trial Overview of Pathfinder Therapeutics, Inc. 50
AstraZeneca PLC 51
Clinical Trial Overview of AstraZeneca PLC 51
Jennerex Biotherapeutics, Inc. 52
Clinical Trial Overview of Jennerex Biotherapeutics, Inc. 52
GlaxoSmithKline plc 53
Clinical Trial Overview of GlaxoSmithKline plc 53
Eli Lilly and Company 54
Clinical Trial Overview of Eli Lilly and Company 54
F. Hoffmann-La Roche Ltd. 55
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 55
Merck & Co., Inc. 56
Clinical Trial Overview of Merck & Co., Inc. 56
Light Sciences Oncology, Inc. 57
Clinical Trial Overview of Light Sciences Oncology, Inc. 57
Kowa Company, Ltd. 58
Clinical Trial Overview of Kowa Company, Ltd. 58
ArQule, Inc. 59
Clinical Trial Overview of ArQule, Inc. 59
BioAlliance Pharma SA 60
Clinical Trial Overview of BioAlliance Pharma SA 60
Eisai Inc. 61
Clinical Trial Overview of Eisai Inc. 61
Bio-Cancer Treatment International Limited 62
Clinical Trial Overview of Bio-Cancer Treatment International Limited 62
Clinical Trial Overview of Top Universities / Institutes / Hospitals 63
Eastern Hepatobiliary Surgery Hospital 63
Clinical Trial Overview of Eastern Hepatobiliary Surgery Hospital 63
The University of Texas M. D. Anderson Cancer Center 66
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 66
Sun Yat-sen University 69
Clinical Trial Overview of Sun Yat-sen University 69
FUDAN University 71
Clinical Trial Overview of FUDAN University 71
Memorial Sloan Kettering Cancer Center 73
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 73
National Taiwan University Hospital 75
Clinical Trial Overview of National Taiwan University Hospital 75
Massachusetts General Hospital 76
Clinical Trial Overview of Massachusetts General Hospital 76
National Cancer Center Hospital 78
Clinical Trial Overview of National Cancer Center Hospital 78
University of Pittsburgh 79
Clinical Trial Overview of University of Pittsburgh 79
Stanford University 80
Clinical Trial Overview of Stanford University 80
Seoul National University Hospital 81
Clinical Trial Overview of Seoul National University Hospital 81
West China Hospital 82
Clinical Trial Overview of West China Hospital 82
University Health Network 83
Clinical Trial Overview of University Health Network 83
Kaohsiung Medical University Chung-Ho Memorial Hospital 84
Clinical Trial Overview of Kaohsiung Medical University Chung-Ho Memorial Hospital 84
University of Milan 85
Clinical Trial Overview of University of Milan 85
Roswell Park Cancer Institute 86
Clinical Trial Overview of Roswell Park Cancer Institute 86
Mayo Clinic 87
Clinical Trial Overview of Mayo Clinic 87
Kurume University 88
Clinical Trial Overview of Kurume University 88
Queen Mary Hospital 89
Clinical Trial Overview of Queen Mary Hospital 89
Kyoto University 90
Clinical Trial Overview of Kyoto University 90
Five Key Clinical Profiles 91

Appendix 156
Abbreviations 156
Definitions 156
Research Methodology 157
Secondary Research 157
About GlobalData 158
Contact Us 158
Disclaimer 158
Source 159

List of Tables


Liver Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8
Liver Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Liver Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11
Liver Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12
Liver Cancer Therapeutics Clinical Trials, North America, Top Five Countries, 2012* 13
Liver Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012* 14
Liver Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 15
Liver Cancer Therapeutics Clinical Trials, BRIC Countries, 2012* 16
Liver Cancer Therapeutics Clinical Trials, G7 Countries, 2012* 17
Liver Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Liver Cancer Therapeutics Clinical Trials, E7 Countries, 2012* 19
Liver Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
Liver Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21
Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 22
Liver Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Liver Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2012* 24
Liver Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 26
Liver Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012* 28
Liver Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 36
Liver Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 38
Liver Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 40
Liver Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 41
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012* 42
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012* 44
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 45
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Taiho Pharmaceutical Co., Ltd., 2012* 46
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 47
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 48
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Celsion Corporation, 2012* 49
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pathfinder Therapeutics, Inc., 2012* 50
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 51
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Jennerex Biotherapeutics, Inc., 2012* 52
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 53
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 54
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012* 55
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 56
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Light Sciences Oncology, Inc., 2012* 57
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Kowa Company, Ltd., 2012* 58
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ArQule, Inc., 2012* 59
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by BioAlliance Pharma SA, 2012* 60
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012* 61
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bio-Cancer Treatment International Limited, 2012* 62
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Hepatobiliary Surgery Hospital, 2012* 63
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 66
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2012* 69
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2012* 71
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012* 73
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2012* 75
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012* 76
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Center Hospital, 2012* 78
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012* 79
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012* 80
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2012* 81
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by West China Hospital, 2012* 82
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2012* 83
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaohsiung Medical University Chung-Ho Memorial Hospital, 2012* 84
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Milan, 2012* 85
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012* 86
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 87
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Kurume University, 2012* 88
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen Mary Hospital, 2012* 89
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2012* 90

List of Figures


Liver Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8
Liver Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Liver Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11
Liver Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12
Liver Cancer Therapeutics Clinical Trials, North America, Top Five Countries (%), 2012* 13
Liver Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012* 14
Liver Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 15
Liver Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16
Liver Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012* 17
Liver Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Liver Cancer Therapeutics Clinical Trials, E7 Countries (%), 2012* 19
Liver Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
Liver Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21
Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 22
Liver Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Liver Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 36
Liver Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 37
Liver Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 39
Liver Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 41
GlobalData Methodology 157

Upcoming Reports:

Middle East Cyber Security Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020
By - Transparency Market Research
Cyber security (or computer security) refers to the security applied to entire web (cyber) world, which includes everything from computers to smartphone and other automated devices with web-connectivity. The prime objective is to ensure the confidentiality of the information shared across the network. It is also applied to data monitoring in public and private computer networks including the internet to ensure information security. The cyber security enables protection from attacks such as unauthorized access, hacking, injection of codes such as virus and Trojans and other vulnerabilities....
MTOR Inhibitors Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2014 - 2020
By - Transparency Market Research
Mammalian target of rapamycin (mTOR) is a protein that regulates vital cell growth processes in a living organism. mTOR acts as a communication command centre in human body by receiving external signals from growth factors, hormones, proteins and transfer the signal to on' or 'off' mode for the cell to grow and divide. mTOR is considered as a member of the phosphatidylinositol 3-kinase (PI3K) cell survival pathway which plays an important role in the regulation of cell growth and proliferation. Akt proteins can be able to activate mTOR, which promotes cell growth and proliferation by...
Automotive Electronics Control Unit Management (ECU/ECM) Market - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2013 - 2019
By - Transparency Market Research
Automotive Electronics are intensively used in automobiles sectors for providing better engine control.Automobiles sector has become more dependent on electronicsas this machines help inproviding higher level of safety. At present, contemporary cars havedevelopedthe advance machinery which controls the operations with electronic control units (ECUs). Premium segment car consist of 150 EUCs for virtually controlling of vehicle.These car using ECUs for managing efficiency, navigating and mount system solutions for preventing accidents. The telematics system including local hot spots...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Does Chewing Gum Lead to Academic Productivity?
Aug 20, 2014  
Could chewing gum actually lead to improved academic productivity? A study conducted recently has found that there may possibly be a link between the two, finally making some headway in a decade-old research. The study called ‘The Effects of Gum Chewing on Math Scores in Adolescents’ was led by Craig Johnston from Baylor College of Medicine in Houston, Texas, and was sponsored by...
German Arms Industrys Outlook Uncertain
Aug 20, 2014  
During a recent meeting between representatives of the German ammunition and arms industry and the German Ministry for Economic Affairs, the unionists discussed concerns about the declining approvals for German arms shipment contracts. Workers’ representatives had, earlier in July 2014, written to the German minister of economic affairs Sigmar Gabriel stating that these curbs on...
Microcontrollers Market Poised to Witness Full-Blown Recovery
Aug 20, 2014  
The microcontrollers industry may well be on the verge of a full-blown recovery thanks to a rebound in sales to automotive and industrial customers. Analysts say that this recovery isn’t limited to the 32-bit market. Signs of growth are also being seen in the 8-bit industry, with a higher inflow of new orders.  The growth has been so encouraging that Arizona-based Microchip...
US Vessel Cape Ray Destroyed Syrias Chemical Weapons
Aug 19, 2014  
RIA Novosti, Monday news stated that teams aboard the MV Cape Ray (US vessel) have completed the task of neutralizing the chemical stockpile materials declared in Syria. This was informed by John Kirby, Pentagon Press Secretary Rear Adm. The Secretary of Defense – Chuck Hagel congratulated the Navy Captain – Rich Dromerhauser ship's crew on completing their task of...
Surge in Bourbon Production
Aug 19, 2014  
America’s bourbon whiskey manufacturer, Kentucky, has taken a decision on hoarding large stockpiles of bourbon whiskey. According to sources, distillers are stocking up the huge quantities of bourbon even before the demand for the same has arisen in the market.  This step of excess production involves a certain risk, but as soon as the market demand for this dominates the...